Teconyx 400 Injection
Product Info
| Prescription required | Yes |
| Marketer | NYX Pharmaceutical Pvt Ltd |
| Active Ingredient | Teicoplanin (400mg) |
| Storage | Store below 30°C |
| Chemical Class | Glycopeptide antibiotics |
| Habit Forming | No |
| Therapeutic Class | ANTI INFECTIVES |
| Action Class | Glycopeptides |
| User Rating | 4.8 |
| User Reviews | 426 |
FAQ
What if you forget to take Teconyx Injection?
If you miss a dose of Teconyx 400, consult your doctor.
Teconyx 400 Injection Reviews
Teconyx 400 is an antibiotic used in the treatment of severe bacterial infections in hospitalized patients. It is effective against infections of the respiratory tract (eg. pneumonia), urinary tract, skin and soft tissues, bones and joints, heart, blood, and others.
Teconyx 400 works by stopping the growth of bacteria and is useful for treating adults as well as children. It is a narrow-spectrum antibiotic that only covers the gram-positive type of bacteria. This medicine is given by drip or by direct injection into a vein, under the supervision of a healthcare professional. It may also be combined with other antibiotics to treat additional types of bacteria.
Some people may develop local injection site reactions like pain, swelling, redness. However, this is usually minor and temporary. Other side effects like fever, itching, and skin rash may be seen occasionally. Monitoring with regular kidney function tests may be needed while you are being treated with this medication. Inform your doctor if you have a history of an allergic reaction to this medication in the past. Use caution while driving or doing anything that requires concentration as it may cause dizziness and headaches. Consult your doctor if you are pregnant or breastfeeding before taking this medicine.
Teconyx 400 works by stopping the growth of bacteria and is useful for treating adults as well as children. It is a narrow-spectrum antibiotic that only covers the gram-positive type of bacteria. This medicine is given by drip or by direct injection into a vein, under the supervision of a healthcare professional. It may also be combined with other antibiotics to treat additional types of bacteria.
Some people may develop local injection site reactions like pain, swelling, redness. However, this is usually minor and temporary. Other side effects like fever, itching, and skin rash may be seen occasionally. Monitoring with regular kidney function tests may be needed while you are being treated with this medication. Inform your doctor if you have a history of an allergic reaction to this medication in the past. Use caution while driving or doing anything that requires concentration as it may cause dizziness and headaches. Consult your doctor if you are pregnant or breastfeeding before taking this medicine.
How Teconyx 400 Injection Works
Teconyx 400 is an antibiotic. It kills bacteria by preventing them from forming the bacterial protective covering (cell wall) which is needed for them to survive.
How to Use Teconyx 400 Injection
Your doctor or nurse will give you this medicine. Kindly do not self administer.
Benefits of Teconyx 400 Injection
- In Severe bacterial infections: Teconyx 400 works by killing bacteria which can cause serious infections. It is used to treat many different types of bacterial infections such as infections of the lungs (pneumonia) and urinary tract. It is given by a doctor or nurse into a vein and should not be self-administered. Teconyx 400 usually makes you feel better very quickly but you should continue taking it as prescribed even when you feel better to make sure that all bacteria are killed and do not become resistant.
Uses of Teconyx 400 Injection
- Severe bacterial infections
Teconyx 400 Injection Side Effects
Safety Tips
Pregnancy
CONSULT YOUR DOCTOR
Teconyx 400 may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Alcohol
SAFE
Consuming alcohol with Teconyx 400 does not cause any harmful side effects.
Kidney
CAUTION
Teconyx 400 should be used with caution in patients with kidney disease. Dose adjustment of Teconyx 400 may be needed. Please consult your doctor.
Liver
SAFE IF PRESCRIBED
Teconyx 400 is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Teconyx 400 may not be needed in these patients. Please consult your doctor.
Driving
UNSAFE
Teconyx 400 may cause side effects which could affect your ability to drive.You may have headaches or feel dizzy while being treated with Teconyx 400. If this happens, do not drive.
Breast feeding
SAFE IF PRESCRIBED
Teconyx 400 is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Quick Tips
- Use caution while driving or doing anything that requires concentration as it can cause dizziness and headaches.
- It is given by an injection or drip into a vein or into a muscle.
- Teconyx 400 is used for treating serious bacterial infections, which cannot be treated with other antibiotics like penicillins and cephalosporins.
- Do not take Teconyx 400 if you are pregnant or breastfeeding.
- Finish the prescribed course, even if you start to feel better. Stopping it early may make the infection come back and harder to treat.
References
- MacDougall C, Chambers HF. Protein Synthesis Inhibitors and Miscellaneous Antibacterial Agents. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. pp. 1539-42.
- Chambers HF, Deck DH. Beta-Lactam and Other Cell Wall- & Membrane-Active Antibiotics. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 787.
- Central Drugs Standard Control Organisation (CDSCO).
- Teicoplanin. Guildford, Surrey: SANOFI; 1989 [revised 12 Dec. 2017].